Lixisenatide, Glulisine Beneficial As Add-On to Basal Insulin

05 Jul 2016


A study published in Diabetes Care shows that Lixisenatide and Glulisine, as add-ons to basal insulin, result in reduced glycated hemoglobin levels in patients with type 2 diabetes.

Endocrinology Advisor


Related Topics

Diabetes

Share this story